Literature DB >> 24076114

Rotavirus in adults, Brazil, 2004-2011: G2P[4] dominance and potential impact on vaccination.

Adriana Luchs1, Audrey Cilli2, Simone Guadagnucci Morillo2, Rita de Cassia Compagnoli Carmona2, Maria do Carmo Sampaio Tavares Timenetsky2.   

Abstract

OBJECTIVES: The aim of this study was to monitor rotavirus (RV) infections in adults >18 years with acute gastroenteritis during 2004-2011 national Brazilian RV surveillance. In addition, to characterize the RV group A (RVA) strains in order to gain insight into the supposed vaccine selective pressure imposed to Brazilian children population.
METHODS: A total of 2102 convenient fecal specimens were investigated by ELISA, PAGE, and RT-PCR.
RESULTS: RV was detected in 203 (9.6%) of 2102 specimens, and showed a marked peak of detection in September. RVA infection was detected in 9.4% (197/2102) and RV group C (RVC) in 0.3% (6/2102). The most frequent genotypes detected in 2004 and 2005 were G9P[8] (38.5%; 5/13) and G1P[8] (54.5%; 6/11), respectively. The dominant genotype identified from 2006 to 2011 was G2P[4] (64.4%; 116/180). Detection rate varied during the 8-year period of the study from 0.7% to 12.9%.
CONCLUSION: The high detection rate of G2P[4] in adults provides further evidence that its dominance reflects the seasonality of RVA strains instead of the supposed selective advantage created by vaccination program. It also can be suggested that adult infections may serve as a reservoir to maintain RVA strains in childhood gastroenteritis. Considering the detection rate, the evident reduction of RVA frequency observed in children after vaccine introduction was not present in adults.
Copyright © 2013 Elsevier Editora Ltda. All rights reserved.

Entities:  

Keywords:  Adults; Brazil; Rotavirus group A; Rotavirus group C; Vaccination

Mesh:

Substances:

Year:  2013        PMID: 24076114      PMCID: PMC9425225          DOI: 10.1016/j.bjid.2013.05.010

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   3.257


Introduction

Rotaviruses (RV) are double-stranded RNA (dsRNA) viruses comprising the genus Rotavirus in the family Reoviridae. Three of the seven identified groups of RV infect humans. Group A rotavirus (RVA), the most common cause of diarrhea in infants and young children throughout the world, accounts for the large percentage of pediatric hospitalizations. As a pathogen of adults, RVA has frequently been overlooked.3, 4 Some authors have reported RVA cases in elderly and immune compromised individuals.5, 6 Both VP7 and VP4, outer proteins layer, are used to further categorize RVA into G (Glycoprotein) and P (Protease) genotypes. The most common G types detected are G1, G2, G3, G4 and G9, while in P typing P[4], P[6] and P[8] are the most frequently isolated.7, 8 RVA infection and circulating genotypes in children in Brazil have been well characterized.9, 10 Nevertheless, limited information is available on the genotypes infecting adults.8, 11 In addition, a high prevalence of G2P[4] was lately reported in Brazil and linked with universal RVA vaccination program using a G1P[8] live oral vaccine suggesting that this monovalent vaccine possibly created conditions in which G2P[4] could acquire selective advantage over P[8] genotypes. Nevertheless, a temporal periodicity, within ≈10 year cyclic pattern of G2P[4] has also been observed in Brazil, and should have been considered as an alternative explanation to the increased detection of this genotype since 2006. The molecular characterization of RVA genotypes circulating in adults could help to solve this question. Group B (RVB) and group C (RVC) rotavirus are morphologically identical to RVA, but their dsRNA presents distinct migration patterns on polyacrylamide gels and they are not detected by common enzyme immunoassays (EIAs) for RVA. RVB has been associated with outbreaks of diarrhea in adults in China, India, and Bangladesh.15, 16 RVC has been associated with either sporadic diarrheal illness or limited outbreaks of illness in various settings, 15, 17, 18 including Brazil.19, 20, 21, 22 The aim of this work was to monitor RV infections in adults >18 years old with acute gastroenteritis during 2004–2011 national Brazilian RV surveillance. Additionally, to characterize the RVA strains (G- and P-type) circulating in the adult community during this study period in order to gain insight into the supposed vaccine selective pressure imposed to Brazilian children population.

Material and methods

Fecal samples

This is a retrospective and descriptive study conducted from 2004 to 2011 with convenient sampling from surveillance specimen collected from adults >18 years old presenting acute gastroenteritis. Stool samples from patients with acute gastroenteritis were sent to the Enteric Diseases Laboratory of the Adolfo Lutz Institute, regional reference center for rotavirus surveillance, Ministry of Health – Brazil, and a member of Acute Diarrhea Disease Monitoring Program, State Department of Health. The aim of this program is the early detection of outbreaks of diarrhea with national scope. In this study, clinical samples from the following States were used: São Paulo (SP), Mato Grosso (MT), Mato Grosso do Sul (MS), Paraná (PR), Tocantins (TO), Goiás (GO), Santa Catarina (SC), and the Federal District (FD) (Fig. 1).
Fig. 1

The states highlighted in black collected stool samples from patients with acute gastroenteritis, screened for rotavirus group A infection and sent to the Enteric Diseases Laboratory of the Adolfo Lutz Institute. Adolfo Lutz Institute is Regional Reference Center for rotavirus surveillance and a member of Acute Diarrhea Disease Monitoring Program with national scope.

The states highlighted in black collected stool samples from patients with acute gastroenteritis, screened for rotavirus group A infection and sent to the Enteric Diseases Laboratory of the Adolfo Lutz Institute. Adolfo Lutz Institute is Regional Reference Center for rotavirus surveillance and a member of Acute Diarrhea Disease Monitoring Program with national scope.

Rotavirus detection

A total of 2102 stool samples were tested. RVA was detected using commercial immunoenzymatic assays (Premier™ Rotaclone®, Meridian Bioscience, Inc., USA; or RIDASCREEN® Rotavirus, RBiopharm AG, Darmstadt, Germany) performed according to the manufacturer's instructions. RVA ELISA negative samples were tested further for the presence of RVC by polyacrylamide gel electrophoresis (SDS–PAGE) according to standard procedures, and confirmed by RT-PCR assay.

RNA extraction and RT-PCR

RVA and RVC dsRNA was extracted directly from stools using Trizol® reagent (Invitrogen, Carlsbad, CA, USA), according to the manufacturer's instructions or by QIAamp® Viral RNA Mini kit (Qiagen, Valencia, CA), and stored at −70 °C. The reverse transcriptase polymerase chain reactions (RT-PCR) for RVA VP7 and VP4 genes were performed according to the protocols previously described.25, 26 RT-PCR protocol used to amplify a fragment of the RVC VP6 gene was described by Gouvea et al.

Results

RV was detected in 203 (9.6%) of 2102 specimens collected from adults (Table 1). RV infection was found predominantly in the winter and in drier months, with peak in September (Fig. 2A). Temporal analysis of RV infection allowed the identification of two sections. The first section, between 2004 and 2007, did not reveal clear peak of RV detection, but rather a tendency of RV detection among August, September and, October (Fig. 2B). The second section, between 2008 and 2011, showed a marked peak of RV detection occurring in September (Fig. 2C). RVA infection was detected in 9.4% of the samples (197/2102) and RVC in 0.3% (6/2102). RVC cases were detected only in 2008 (3.4%; 6/178) (Table 1).
Table 1

Rotavirus genotyping results from adults ≥18 years old presenting acute gastroenteritis, Brazil, 2004–2011.

Rotavirus genotypeYear
2004% (No.)2005% (No.)2006% (No.)2007% (No.)2008% (No.)2009% (No.)2010% (No.)2011% (No.)Total % (No.)
G1P[4]1.9% (1)25.0% (2)1.7% (3)
G1P[8]30.7% (4)54.5% (6)7.7% (4)7.8% (14)
G2P[4]59.7% (31)62.5% (5)77.3% (17)90.4% (57)60% (6)64.5% (116)
G3P[8]9.1% (1)4.8% (3)2.2% (4)
G9P[8]38.5% (5)9.1% (1)9.6% (5)10% (1)6.7% (12)
G2 + G9P[NT]3.8% (2)1.1% (2)
G2 + G3P[4] + [8]1.6% (1)0.5% (1)
G9P[NT]15.4% (2)1.6% (1)1.7% (3)
G1P[NT]5.8% (3)1.7% (3)
G2P[NT]1.9% (1)4.5% (1)20% (2)2.2% (4)
GNTP[8]7.7% (1)0.5% (1)
GNTP[4]10% (1)0.5% (1)
GNTP[NT]7.7% (1)27.3% (3)9.6% (5)12.5% (1)18.2% (4)100% (1)1.6% (1)8.9% (16)
Total of genotyped samples68.4% (13)91.7% (11)96.3% (52)80.0% (8)95.6% (22)100% (1)92.6% (63)100% (10)91.4% (180)
RT-PCR negative31.6% (6)8.3% (1)3.7% (2)20.0% (2)4.4% (1)7.4% (5)8.6% (17)
Total RVA ELISA positive7.8% (19)4.3% (12)11.2% (54)4.6% (10)12.9% (23)0.7% (1)20.0% (68)4.6% (10)9.4% (197)
RVC3.4% (6)0.3% (6)
Total of samples2442774842171781463392172102

NT, non-typed.

Fig. 2

Temporal distribution of RV positive samples from adults ≥18 years old with acute gastroenteritis, Brazil, 2004–2011 (A), 2004–2007 (B), and 2008–2011 (C).

Rotavirus genotyping results from adults ≥18 years old presenting acute gastroenteritis, Brazil, 2004–2011. NT, non-typed. Temporal distribution of RV positive samples from adults ≥18 years old with acute gastroenteritis, Brazil, 2004–2011 (A), 2004–2007 (B), and 2008–2011 (C). The median age for patients infected with the RVA was 41.5 years old, 63.4% being females. The median age for patients infected with the RVC was 33.3 years old, 66.7% being females. The most frequent genotypes detected in 2004 and 2005 were G9P[8] (38.5%; 5/13) and G1P[8] (54.5%; 6/11), respectively. The dominant genotype identified from 2006 to 2011 was G2P[4] (64.4%; 116/180). Detection rate varied during the 8-year period of the study: 7.8% (19/244) in 2004, 4.3% (12/277) in 2005, 11.2% (54/484) in 2006, 4.6% (10/217) in 2007, 12.9% (23/178) in 2008, 0.7% (1/146) in 2009, 20.0% (68/339) in 2010, and 4.6% (10/217) in 2011 (Table 1).

Discussion

This study was designed to investigate the frequency of RV infection in adults ≥18 years old with acute gastroenteritis and identified the RVA strains in order to investigate possible vaccine impact on the Brazilian pediatric population. In healthy adults, infection causes few or mild symptoms and RV infection is diagnosed via differential diagnosis. However, in immune compromised patients, infection can be severe and persistent. RVA spread occurs mainly through the fecal–oral route, with transmission to adults probably due to caring for sick children or ingestion of contaminated food or water. The peak in RV infections occurred in winter months as it is usually observed in most of the world28, 29, 30; and also mirror the winter RV seasonality of infection observed in pediatric patients.8, 31, 32, 33, 34 In tropical and subtropical settings, the peak of RV infections occurs in cool dry seasons. Strict winter seasonality was also common in the Americas, including Brazil's southern area, although sporadic RV cases and outbreaks can occur all along the year. However, a particular event was observed. The RV detection rate is usually concentrated between June and August in Brazil8, 31, 32, 33, 34; nevertheless, the frequency of RV detection in this study peaked in September, month that marks the beginning of the rainy season. The seasonal patterns and climatic sensitivities of many infectious diseases are well known; and global warming is one of the environmental changes now under way. It can be suggested that this climatic variation could promote a range of impacts upon the occurrence of RV infection in the Brazilian population. The frequency of RVA infection in adults detected in this work (9.4%) was lower than that observed in studies carried out in Japan (14%), United States (18%) and Paraguay (17.3%), but was similar to the frequency found in China (9%). A previous study conducted in Brazil showed that RVA rate among adults was 7.1%, comparable to the incidence observed in India (7%). The overall percentage of RVA detected among children in Brazil has been much higher (∼30%) than that found in adults.8, 9 A significant reduction in the frequency of RVA detection in children with gastroenteritis was observed in Brazil after the RVA vaccine introduction; nonetheless, the present study showed that this decrease was not evident in adult inhabitants. On the other hand, Anderson et al. showed that the prevalence of RVA among adults declined from 4.35% in 2006–2007 (prepediatric impact era) to 2.24% in 2008–2010 (pediatric impact era) in USA, suggesting an indirect protection of adults from RVA by pediatric RVA vaccination. Considering RVA annual frequency, a low rate of RVA infection was observed in 2009. A similar lack of a RVA season in Brazil during 2009 has been previously described.10, 42, 43 According to the National Meteorology Institute (INMET) records, during the year of 2009, Brazil experienced an atypical raining winter season with higher average rainfall record due to the El Niño phenomenon (http://www.inmet.gov.br). Therefore, this climatic condition could have been involved in the low detection frequency observed. A variety of RVA genotypes among adults was described all over the world.11, 14, 44, 45, 46, 47 Throughout the study period, G2P[4] was the most frequent strain in adults (64.5%). G1P[8] and G9P[8] were the most frequent types in 2004–2005, matching to the results of numerous studies focusing RVA G type distribution in many countries, including Brazil.8, 48 However these strains were displaced by G2P[4] during the 2006 season. Recently, a high prevalence of G2P[4] in children was reported in Brazil and linked to universal RV vaccination program using a G1P[8] live oral rotavirus vaccine. Nevertheless, the high detection rate of G2P[4] in adults provides further evidence that its predominance reflects the epidemic cycle of RVA strains instead of the supposed selective advantage created by the monovalent G1P[8] vaccination program. On the other hand, it also can be suggested that adult infections may serve as a reservoir to maintain RVA strains in childhood gastroenteritis. In addition, the same strains detected in adults during the study period were known to be circulating in children according to Laboratory records. G4P[8] strain is one of the most common combinations found in humans worldwide, however, it was not detected in this study. At a global level, the weighted prevalence of G4 decreased slightly during 1996–2007. The seasonal shifts of RVA strains is a possible mechanism used by the virus to evade herd immunity acquired by previous infections, and thus, ultimately persist in the human population. The changing pattern of circulating RVA types associated with greatly reduced diversity of strains may have important implications for the evolution of RVA strains. It is worth mentioning that RVA genotyping by RT-PCR presents some limitations. RT-PCR is the method of choice for typing RVA and is regarded as the gold standard. However, the accumulation of point mutations at primer binding sites has been linked with mistyping or failure to identify genotype correctly. Regularly validation of PCR results with sequencing is important, especially in mixed RVA infections. In addition, in the present study RVA positive samples could not be genotyped by multiplex RT-PCR. Unfortunately, non-typeable RVA strains have been reported in almost every epidemiological survey around the world, regardless of the methodology employed. RVC infection in adults has received negligible attention. Only a few studies documented the RVC occurrence in adults, most of them based on serological evidence.16, 53, 54, 55 In Brazil, RVC was previously detected both in sporadic cases and outbreaks affecting adults.20, 21, 22 The RVC detection rate observed in this work (0.3%) was lower than that observed in a study carried out with adults in Sweden (∼1%). It is noted that the RVC incidence and associated disease remain unclear once sensitive tests for its detection are not available to clinical laboratories. The diagnosis is difficult since most of the EIA assays do not recognize the RVC specific VP6 antigen. The RT-PCR using RVC specific primer is a convenient option; however, it has not been used widely due to the large costs for routine surveillance. The PAGE analysis of dsRNA requires the presence of 108–1010 viral particles/ml for a positive result; nevertheless, this method has sufficient sensitivity to detect RVC with low costs. In conclusion, this study adds further evidence that RV is a minor cause of acute adult gastroenteritis in Brazil. On the other hand, contributes significantly to the understanding of RV infections in mature population. The results also suggest that adults are susceptible to the same types of RVA at the same season of the year as children. It is still unknown whether the burden of RVA in adults will remain unchanged subsequently after widespread impact of RVA vaccination observed in children. The finding of different genotypes in the adult population highlights the need for continuing surveillance in both pediatric and mature populations, to monitor the suitability of vaccines and to correlate vaccine efficacy with continuing virus evolution. The dynamics between pediatric and adult RVA infection remains unclear, and adult infections may serve as another source of RVA genomic diversity.

Ethical approval

This study was carried out in accordance with the Declaration of Helsinki as revised in 2000, and approved by the Ethics Committee of the Adolfo Lutz Institute, São Paulo. Study participants were not required to provide informed consent as this study was considered by the Ethics Committee to be part of routine surveillance activities.

Author contributions

AL and MCSTT conceived and designed the study; AL, AC, SGM, RCCC acquired the data, performed the immunoenzymatic assays, and the molecular typing of the strains; AL analyzed the data and wrote the manuscript; AC, SGM, RCCC and MCSTT critically revised the manuscript. All authors read and approved the final version. AL and MCSTT are guarantors of the paper.

Conflicts of interest

The authors declare no conflicts of interest.
  55 in total

1.  Characterization of rotavirus strains from day care centers: pre- and post-rotavirus vaccine era.

Authors:  Simone G Morillo; Adriana Luchs; Audrey Cilli; Fernanda F Costa; Rita de Cassia C Carmona; Maria do Carmo S T Timenetsky
Journal:  J Pediatr (Rio J)       Date:  2010 Mar-Apr       Impact factor: 2.197

2.  Development and validation of DNA microarray for genotyping group A rotavirus VP4 (P[4], P[6], P[8], P[9], and P[14]) and VP7 (G1 to G6, G8 to G10, and G12) genes.

Authors:  Shinjiro Honma; Vladimir Chizhikov; Norma Santos; Masatoshi Tatsumi; Maria do Carmo S T Timenetsky; Alexandre C Linhares; Joana D'Arc P Mascarenhas; Hiroshi Ushijima; George E Armah; Jon R Gentsch; Yasutaka Hoshino
Journal:  J Clin Microbiol       Date:  2007-06-13       Impact factor: 5.948

3.  Rotavirus in adults requiring hospitalization.

Authors:  Evan J Anderson; Ben Z Katz; Jennifer A Polin; Susheel Reddy; Melissa H Weinrobe; Gary A Noskin
Journal:  J Infect       Date:  2011-09-16       Impact factor: 6.072

4.  Indirect protection of adults from rotavirus by pediatric rotavirus vaccination.

Authors:  Evan J Anderson; Deanna B Shippee; Melissa H Weinrobe; Melissa D Davila; Ben Z Katz; Susheel Reddy; Mary Gene Karen P Cuyugan; Samuel Y Lee; Yael M Simons; Ram Yogev; Gary A Noskin
Journal:  Clin Infect Dis       Date:  2013-01-23       Impact factor: 9.079

5.  [Incidence of rotavirus in adults with diarrhea in Asunción, Paraguay].

Authors:  M Martínez; N Fariña; M Rodríguez; G Russomando; G I Parra
Journal:  Rev Argent Microbiol       Date:  2005 Apr-Jun       Impact factor: 1.852

6.  Characterization of human group C rotavirus in Argentina.

Authors:  A A Castello; M H Argüelles; G A Villegas; N López; D P Ghiringhelli; L Semorile; G Glikmann
Journal:  J Med Virol       Date:  2000-10       Impact factor: 2.327

7.  Detection and molecular characterization of group A rotavirus from hospitalized children in Rio de Janeiro, Brazil, 2004.

Authors:  Filipe Anibal Carvalho-Costa; Rosane Maria Assis; Alexandre Madi Fialho; Márcio Neves Bóia; Daniele Pires Dias Alves; Carolina Maria Miranda de Assis Martins; José Paulo Gagliardi Leite
Journal:  Mem Inst Oswaldo Cruz       Date:  2006-05       Impact factor: 2.743

8.  Rotavirus infections and climate variability in Dhaka, Bangladesh: a time-series analysis.

Authors:  M Hashizume; B Armstrong; Y Wagatsuma; A S G Faruque; T Hayashi; D A Sack
Journal:  Epidemiol Infect       Date:  2007-11-08       Impact factor: 2.451

9.  Global climate change and emerging infectious diseases.

Authors:  J A Patz; P R Epstein; T A Burke; J M Balbus
Journal:  JAMA       Date:  1996-01-17       Impact factor: 56.272

10.  Molecular characterization of group A rotavirus found in elderly patients in Ireland; predominance of G1P[8], continued presence of G9P[8], and emergence of G2P[4].

Authors:  L Gunn; S A Feeney; O Cashman; P J Collins; P V Coyle; H O'Shea
Journal:  J Med Virol       Date:  2012-12       Impact factor: 2.327

View more
  6 in total

1.  Rotavirus vaccination takes seasonal signature of childhood diarrhea back to pre-sanitation era in Brazil.

Authors:  Julia M Baker; Wladimir J Alonso
Journal:  J Infect       Date:  2017-10-12       Impact factor: 6.072

2.  Rotavirus Disease and Genotype Diversity in Older Children and Adults in Australia.

Authors:  Celeste M Donato; Susie Roczo-Farkas; Carl D Kirkwood; Graeme L Barnes; Julie E Bines
Journal:  J Infect Dis       Date:  2022-06-15       Impact factor: 7.759

3.  Case-control study of diarrheal disease etiology in individuals over 5 years in southwest China.

Authors:  Shun-Xian Zhang; Chun-Li Yang; Wen-Peng Gu; Jia-Xu Chen; Xiao-Nong Zhou; Lin Ai; Emmanuel Serrano; Pin Yang; Xia Zhou; Shi-Zhu Li; Shan Lv; Zhi-Sheng Dang; Jun-Hu Chen; Wei Hu; Li-Guang Tian
Journal:  Gut Pathog       Date:  2016-11-16       Impact factor: 4.181

4.  Human rotavirus strains circulating in Venezuela after vaccine introduction: predominance of G2P[4] and reemergence of G1P[8].

Authors:  Esmeralda Vizzi; Oscar A Piñeros; M Daniela Oropeza; Laura Naranjo; José A Suárez; Rixio Fernández; José L Zambrano; Argelia Celis; Ferdinando Liprandi
Journal:  Virol J       Date:  2017-03-21       Impact factor: 4.099

Review 5.  Efficacy, safety and effectiveness of licensed rotavirus vaccines: a systematic review and meta-analysis for Latin America and the Caribbean.

Authors:  Raúl F Velázquez; Alexandre C Linhares; Sergio Muñoz; Pamela Seron; Pedro Lorca; Rodrigo DeAntonio; Eduardo Ortega-Barria
Journal:  BMC Pediatr       Date:  2017-01-13       Impact factor: 2.125

Review 6.  Group A rotavirus gastroenteritis: post-vaccine era, genotypes and zoonotic transmission.

Authors:  Adriana Luchs; Maria do Carmo Sampaio Tavares Timenetsky
Journal:  Einstein (Sao Paulo)       Date:  2016 Apr-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.